DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Arcutis - 2 Dow - 1 we'll - 1 bode - 1 We're - 1 Li Auto - 1 Krystal - 1 MARA - 1
Top related locs:
U.S New York City Salesforce Maxx Bank of Nova Scotia BlackRock Cayman FactSet
Top related orgs:
New York Stock Exchange - 2 Nvidia - 1 Nasdaq - 1 Dow Jones - 1 Dow - 1 Palo Alto Networks - 1 Bausch Health - 1 Coterra Energy - 1

Search resuls for: "Arcutis"


5 mentions found


☆ Fed's favorite inflation gauge looms next week — plus, what we want from 2 portfolio earnings reports
  + stars: | 2024-02-24 | by ( Zev Fima | ) www.cnbc.com   time to read: +10 min
Wall Street returned to its winning ways this week — and Nvidia 's blowout earnings report Wednesday night was a big reason why. Twenty-six of our 32 portfolio stocks have delivered their results this earnings season (we didn't own Abbott Labs at the time of its report). It was a muted week for macroeconomic data, but we did get a slightly better-than-expected January existing home sales report on Thursday. In the week ahead, two more Club names are set to report earnings before a market-moving economic update arrives Thursday morning. The two other reports of note are the January new home sales report on Monday and ISM Manufacturing report on Friday.
Persons: Dow, we'll, bode, We're, Li Auto, Krystal, Arcutis, MARA, Iovance, Goldman Sachs BDC, CRON, BUD, Papa, LEV, Ginkgo, Jim Cramer's, Jim Cramer, Jim, Spencer Platt Organizations: Nvidia, Nasdaq, Dow Jones, Dow, Palo Alto Networks, Bausch Health, Coterra Energy, Abbott, Companies, TJX, Marshalls, TJX Companies, Berkshire Hathaway, Krystal Biotech, Alpha Metallurgical Resources , Inc, Fidelity National Information Services Inc, Animal Health, ELAN, Public Service Enterprise Group, Surgery Partners, BioCryst Pharmaceuticals Inc, Outdoor Holdings, Enlight Renewable Energy Ltd, Kosmos Energy, Playtika, Video Communications, TiRobot Corp, IRB, SBAC Communications Corporation, HEICO Corporation, FS KKR, Archer Aviation Inc, TransMedics, Sterling Construction Company, AES, Cruise Line Holdings, Lowe's Companies, American Electric Power Company, Bank of Nova, APLS Pharmaceuticals, Bank of Montreal, BMO, Devon Energy, Solar Inc, Technologies, Lab, Virgin Galactic Holdings, Splunk Inc, eBay, EBAY, Luminar Technologies, Agilent Technologies, G Foods, Masimo Corp, Baidu, Parts Inc, Icahn Enterprises, Viatris Inc, ACM Research, Golden Ocean Group, EMCOR, Industries, NRG Energy, Dycom, Editas, UWM Holdings Corporation, Vistra Energy, Marathon Digital Holdings, AMC Entertainment Holdings, Paramount Global, IonQ Inc, International, HP, Monster Beverage Corporation, Cronos, Birkenstock Holding, Anheuser, Busch InBev, Body, Brink's Company, Flags Inc, Papa John's, ACI, Hormel, Lion Electric Company, BlackRock TCP, Dole plc, DOLE, Fisker Inc, Dell Technologies, Ginkgo Bioworks Holdings, Autodesk, Green Brick Partners, Hewlett Packard Enterprise, Veeva Systems, INTTEST Corporation, Jim Cramer's Charitable, CNBC, New York Stock Exchange, Getty Locations: New York City, U.S, Salesforce, Maxx, Bank of Nova Scotia, BlackRock, Cayman
☆ Investors are ramping up short bets against these electric vehicle makers and small-cap health-care stocks
  + stars: | 2023-08-29 | by ( Nick Wells Hakyung Kim | Nick Wells | Hakyung Kim | ) www.cnbc.com   time to read: +3 min
Electric vehicle companies Lucid , Fisker and Nikola have had a tough year — and Wall Street expects these stocks have even more downside potential. Nikola, which manufactures electric trucks, has seen its short interest jump nearly 14% to 157.7 million shares, or 27.3% of its float. More than a third of Arcutis Biotherapeutics 's free-float shares have been shorted by Wall Street, or 15.5 million shares. Liver disease treatment company Intercept Pharmaceuticals also saw a 12% jump in short interest, with 9.5 million shares sold short. Below is the full list of the most shorted stocks between July 31 and August 15.
Persons: Nikola, Fisker, Arcutis, scPharmaceuticals, Jerry Durso Organizations: EV, IGM Biosciences, Intercept Pharmaceuticals, U.S . Food, Drug Administration, NASH, Intercept, New York Stock Exchange Locations: FactSet, U.S
☆ The most shorted names on Wall Street include a plant-based food stock and five biotechs
  + stars: | 2023-03-28 | by ( Nick Wells Sarah Min | Nick Wells | Sarah Min | ) www.cnbc.com   time to read: +2 min
As of March 15, short interest against Tattooed Chef rose nearly 4% to 17.1 million shares, which is about 35% of the total float, according to FactSet data. The percentage of float refers to the number of shares that are sold short divided by the the total number of shares available for trading. Short interest in another plant-based food company, Beyond Meat, remained elevated even after falling slightly by 2.5% to around 21 million shares. Other companies that saw a surge in short interest this month include a number of biotech companies. In the first half of March, investors increased their bets against Allogene Therapeutics by about 8% to 39.8 million shares, or about half its total float.
☆ 4 major trends in health startups in 2022, after an unexpected post-pandemic dropoff in funding
  + stars: | 2022-12-24 | by ( Riddhi Kanetkar | ) www.businessinsider.com   time to read: +6 min
VCs poured $13.5 billion into healthtech startups in 2022 — down nearly 50% from 2021. But a global slump and the tech downturn changed all of that, and funding into health startups fell by nearly 50% to $13.5 billion this year. AI-driven drug development and mental health startups also boomed during COVID-19 but have seen a funding dropoff in 2022. Tech that served underrepresented groups was spotlightedFrom menopause to mental health, health conditions that were billed as 'taboo' pre-pandemic have come to the forefront this year. Startups offering personalized treatments for niche issues or demographics, such as menopause app Vira Health, mental health platform MyMynd, and men's health platform Numan, all raised capital this year.
☆ Morgan Stanley gives its favorite buy and sell picks into earnings reports
  + stars: | 2022-10-18 | by ( Michelle Fox | ) www.cnbc.com   time to read: +3 min
A highly anticipated corporate earnings season has just kicked off, and Morgan Stanley has highlighted which stocks to buy — or avoid. Given this backdrop, Morgan Stanley analysts looked for stocks that could experience big swings based on near-term catalysts, some positive and others negative. Morgan Stanley sees upside for Arcutis Biotherapeutics if the biotech company's two phase-two studies for its drug Zoryve are successful. "We would expect significant investor focus on these data sets, and our statistical analysis suggests a high probability-of-success (POS) for both trials," wrote Morgan Stanley analyst Vikram Purohit. Meanwhile, Logitech is one of the stocks Morgan Stanley expects to decline due to negative earnings.
0 next >>
Total: 5